Senior insider sale
SVP, Business Development at VANDA PHARMACEUTICALS INC. — senior position signals high conviction
$350.7K
42.43K shares
What this filing means
BIRZNIEKS GUNTHER plans to sell 42.43K shares of VANDA PHARMACEUTICALS INC. valued at approximately $350.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001193125-26-086349
Officer· SVP, Business Development
Since Mar 2026
42.43K
Shares to sell
$350.7K
Approx. market value
42.43K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting/Settlement of Restricted Stock Units
Compensation
3/1/2026
42.43KTotal acquired42.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Vesting/Settlement of Restricted Stock Units Compensation | 42.43K | — |
| Total | 42.43K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
42.43K
Market value
$350.7K
3/2/2026
Total
Units
42.43K
Value
$350.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 42.43K | $350.7K | NASDAQ | Planned |
| Total | 42.43K | $350.7K | ||